The fact that only a fraction of cortical cell bodies accumulated p-tau upon treatment with Hm is consistent with neuropathological reports indicating that tau lesions affect only specific subsets of vulnerable neurons in tauopathies [59,60,61]. The gene discussed is MAPT; the disease is tauopathy.